Search

Search Constraints

You searched for: Author/Creator Yablokova, Vera

Search Results

1. A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial. (28th March 2019)

2. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. Issue 3 (March 2020)

3. Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups. Issue 6 (20th December 2020)